Multi-morphological biodegradable PLGE nanoparticles and their drug release behavior.

Area of Science:

• Polymer Chemistry
• Materials Science
• Nanotechnology

Background:

• Amphiphilic tri-block copolymers are crucial for developing advanced drug delivery systems.
• Controlling nanoparticle morphology is key to optimizing drug encapsulation and release kinetics.
• Biodegradable nanoparticles offer a promising platform for targeted and sustained therapeutic agent delivery.

Purpose of the Study:

• To synthesize and characterize poly(lactide-co-glycolide)-b-poly(ethylene oxide)-b-poly(lactide-co-glycolide) (PLGE) copolymers.
• To fabricate and investigate the morphology of surfactant-free biodegradable PLGE nanoparticles (PLGE-NPs).
• To develop Cyclosporine A (CsA)-loaded PLGE-NPs for potential use as an immunosuppressive agent.

Main Methods:

• Synthesis of PLGE tri-block copolymers with varying segment ratios and molecular weights.
• Fabrication of PLGE-NPs using an improved emulsion/solvent evaporation technique without surfactants.
• Characterization of nanoparticle morphology, size, and degradation behavior.
• In vitro evaluation of CsA release kinetics from loaded PLGE-NPs.

Main Results:

• PLGE copolymers were successfully synthesized, enabling the formation of multi-morphological nanoparticles (spheres, elliptic spheres, rods, threads).
• Nanoparticle morphology was controllable by adjusting copolymer composition (PLGA/PEO ratio) and PEO molecular weight.
• PLGE-NPs demonstrated biodegradability, with degradation rates influenced by copolymer characteristics.
• Tunable in vitro release profiles of CsA were achieved from the fabricated nanoparticles.

Conclusions:

• The study successfully developed a method for creating tunable, multi-morphological, biodegradable PLGE nanoparticles.
• PLGE copolymer composition significantly influences nanoparticle self-assembly and morphology.
• The developed CsA-loaded PLGE-NPs show potential for controlled delivery of immunosuppressive agents.